Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe

Volume 23, Issue 8, July - December 2023 .

Source: Expert Opinion on Biological Therapy - October 26, 2022 Category: Drugs & Pharmacology Authors: Nemanja DamjanovNana KirvalidzeNana KurashviliFausto BertiMatjaz SteigerJoanna SobierskaEric GuenziHendrik OttoAbid SattarHalimu N. HaliduolaElin EdwaldHeimo Stroissniga School of Medicine, University of Belgrade, Belgrade, Serbiab Department of Traumatol Source Type: research